跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT03666650
NCT03666650已完成4 期

Relationship of Edoxaban Plamsa Concentration and Blood Coagulation in Healthy Volunteers Using Standard Laboratory Tests and Viscoelastic Analysis

Turku University Hospital1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2018年11月26日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
15
试验地点
1
主要终点
correlation of edoxaban peak plasma concentrations and viscoelastic analysis
研究概览研究设计入排标准研究组 & 干预措施结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Relationship of edoxaban plasma concentration and blood coagulation in healthy volunteers using standard laboratory tests and viscoelastic analysis

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 40 Years（Adult）
性别
Male
接受健康志愿者
是

入选标准

  • 未提供

排除标准

  • •intolerance of the study drug history of bleeding disorder or similar

研究组 & 干预措施

Rotem

Other

干预措施: Edoxaban 60 MG (Drug)

结局指标

主要结局

correlation of edoxaban peak plasma concentrations and viscoelastic analysis

时间窗: 1 day

viscoelastic test values and blood coagulation laboratory parameters

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Marko Peltoniemi

MD, PhD, Study Principal Investigator, Perioperative Services, Intensive Care and Pain Therapy, Turku University Hospital

Turku University Hospital

研究点 (1)

Loading locations...

相似试验

Unknown
不适用
Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on ThrombelastographyHeart Failure
NCT02448901LifeBridge Health40
进行中（未招募）
3 期
Clinical trial of Edoxaban after surgical bioprosthetic valve replacement
JPRN-jRCT2051210209Izumi Chisato450
已完成
不适用
Anticoagulant effects of Edoxiaban and those inhibitors in patients with venous thromboembolism.Venous thromboembolism (VTE)
JPRN-UMIN000041973Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science243
进行中（未招募）
1 期
Relationship of edoxaban plasma concentration and blood coagulation in healthy volunteers using standard laboratory tests and viscoelastic analysis (EdoRot).Healthy volunteers
EUCTR2018-001265-17-FITurku University Central Hospital15
进行中（未招募）
1 期
Evaluation of Edoxaban in Anticoagulant Naïve patients with normal renal function who are suffering from abnormal and irregular, often rapid heart rate defined as Atrial Fibrillation with no evidence of moderate or severe damage of the heart valves.
EUCTR2016-001795-30-LTDaiichi Sankyo, Inc.600